Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1988; Volume 34,Issue 1
  • You have access
    Oxymetazoline inhibits adenylate cyclase by activation of serotonin-1 receptors in the OK cell, an established renal epithelial cell line.
    T J Murphy and D B Bylund
    Molecular Pharmacology July 1988, 34 (1) 1-7;
  • You have access
    Use of 1-deoxymannojirimycin to show that complex oligosaccharides regulate cellular distribution of the alpha 1-adrenergic receptor glycoprotein in BC3H1 muscle cells.
    B I Terman and P A Insel
    Molecular Pharmacology July 1988, 34 (1) 8-14;
  • You have access
    Synthesis and nephrotoxicity of 6-bromo-2,5-dihydroxy-thiophenol.
    T J Monks, R J Highet, P S Chu and S S Lau
    Molecular Pharmacology July 1988, 34 (1) 15-22;
  • You have access
    Binding kinetics of delta opioid receptors differ for microsomal and synaptic sites.
    J W Spain, D E Petta and C J Coscia
    Molecular Pharmacology July 1988, 34 (1) 23-28;
  • You have access
    Dopamine D1 receptors of the calf parathyroid gland: identification and characterization.
    H B Niznik, E L Fogel, C J Chen, D Congo, E M Brown and P Seeman
    Molecular Pharmacology July 1988, 34 (1) 29-36;
  • You have access
    Isobutylmethylxanthine stimulates adenylate cyclase by blocking the inhibitory regulatory protein, Gi.
    W J Parsons, V Ramkumar and G L Stiles
    Molecular Pharmacology July 1988, 34 (1) 37-41;
  • You have access
    Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit.
    E W Taylor, S S Nikam, G Lambert, A R Martin and D L Nelson
    Molecular Pharmacology July 1988, 34 (1) 42-53;
  • You have access
    Pyrethroid insecticides: stereospecific allosteric interaction with the batrachotoxinin-A benzoate binding site of mammalian voltage-sensitive sodium channels.
    G B Brown, J E Gaupp and R W Olsen
    Molecular Pharmacology July 1988, 34 (1) 54-59;
  • You have access
    Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked.
    J P Arena and R S Kass
    Molecular Pharmacology July 1988, 34 (1) 60-66;
  • You have access
    Cytochrome P-450-dependent biotransformation of a series of phenoxazone ethers in the rat conceptus during early organogenesis: evidence for multiple P-450 isoenzymes.
    H Y Yang, M J Namkung and M R Juchau
    Molecular Pharmacology July 1988, 34 (1) 67-73;
  • You have access
    The role of oxidative and conjugative pathways in the activation of 1,2-dibromo-3-chloropropane to DNA-damaging products in rat testicular cells.
    J G Omichinski, G Brunborg, J A Holme, E J Søderlund, S D Nelson and E Dybing
    Molecular Pharmacology July 1988, 34 (1) 74-79;
  • You have access
    Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
    S A McCluskey, G S Marks, R A Whitney and P R Ortiz de Montellano
    Molecular Pharmacology July 1988, 34 (1) 80-86;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 34, Issue 1
1 Jul 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics